Needham & Company
-
Needham & Company Assumes Alder Biopharm (ALDR) at Buy
-
Alder Biopharm (ALDR) PT Lowered to $26 at Needham & Company; Maintains Buy as Shares 'Underappreciated'
-
Alder BioPharmaceuticals Announces Closing of Public Offering of Common Stock
-
Alder BioPharmaceuticals, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Alder BioPharma (ALDR) Prices 15M Share Offering at $10/Sh
-
Alder BioPharmaceuticals, Inc. Prices Public Offering of Common Stock
-
Alder BioPharma (ALDR) Announces 12.5M Share Common Offering
-
Alder BioPharmaceuticals, Inc. Announces Commencement of Public Offering of Common Stock
-
Needham & Company Starts Alder Biopharm (ALDR) at Buy
-
Alder BioPharmaceuticals to Present at the 16th Annual Needham Healthcare Conference
-
Alder BioPharmaceuticals to Present at 15th Annual Needham Healthcare Conference
-
Pre-Open Stock Movers 03/29: (KERX) (OHRP) (CNL) Higher; (SUNE) (GEVO) (ALXA) Lower (more...)

